Citation: Gr. Bunin et al., PATERNAL AGE AND SPORADIC NEUROFIBROMATOSIS .1. A CASE-CONTROL STUDY AND CONSIDERATION OF THE METHODOLOGIC ISSUES, Genetic epidemiology, 14(5), 1997, pp. 507-516
Authors:
EICHENFIELD LF
LEVY ML
PALLER AS
RICCARDI VM
FARMER ER
CHUANG TY
DINEHART SM
GRAHAM GF
HORDINSKY MK
ODONOGHUE MN
PARISER DM
WEBSTER SB
WHITAKER DC
LOWERY BJ
Citation: Lf. Eichenfield et al., GUIDELINES OF CARE FOR NEUROFIBROMATOSIS TYPE-1, Journal of the American Academy of Dermatology, 37(4), 1997, pp. 625-630
Citation: J. Szudek et al., ASSOCIATIONS OF CLINICAL-FEATURES IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1 (NF1), American journal of human genetics, 61(4), 1997, pp. 646-646
Authors:
BASER ME
RAGGE NK
RICCARDI VM
JANUS T
GANTZ B
PULST SM
Citation: Me. Baser et al., PHENOTYPIC VARIABILITY IN MONOZYGOTIC TWINS WITH NEUROFIBROMATOSIS-2, American journal of medical genetics, 64(4), 1996, pp. 563-567
Authors:
BASER ME
MAUTNER VF
RAGGE NK
NECHIPORUK A
RICCARDI VM
KLEIN J
SAINZ J
PULST SM
Citation: Me. Baser et al., PRESYMPTOMATIC DIAGNOSIS OF NEUROFIBROMATOSIS-2 USING LINKED GENETIC-MARKERS, NEUROIMAGING, AND OCULAR EXAMINATIONS, Neurology, 47(5), 1996, pp. 1269-1277
Authors:
GOLDBERG Y
DIBBERN K
KLEIN J
RICCARDI VM
GRAHAM JM
Citation: Y. Goldberg et al., NEUROFIBROMATOSIS TYPE-1 - AN UPDATE AND REVIEW FOR THE PRIMARY PEDIATRICIAN, Clinical pediatrics, 35(11), 1996, pp. 545-561
Authors:
RUTTLEDGE MH
ANDERMANN AA
PHELAN CM
CLAUDIO JO
HAN FY
CHRETIEN N
RANGARATNAM S
MACCOLLIN M
SHORT P
PARRY D
MICHELS V
RICCARDI VM
WEKSBERG R
KITAMURA K
BRADBURN JM
HALL BD
PROPPING P
ROULEAU GA
Citation: Mh. Ruttledge et al., TYPE OF MUTATION IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) FREQUENTLY DETERMINES SEVERITY OF DISEASE, American journal of human genetics, 59(2), 1996, pp. 331-342
Citation: S. Dublin et al., METHODS FOR RAPID DETECTION OF A RECURRENT NONSENSE MUTATION AND DOCUMENTATION OF PHENOTYPIC FEATURES IN NEUROFIBROMATOSIS TYPE-1 PATIENTS, Human mutation, 5(1), 1995, pp. 81-85
Citation: Vm. Riccardi, SKIN, BLOOD, NERVE-CELLS, AND HERITABILITY - NEW LESSONS FROM NEUROFIBROMATOSIS TYPE-I, Archives of dermatology, 131(8), 1995, pp. 944-944
Citation: Vm. Riccardi et al., NEUROFIBROMATOSIS AND RELATED TUMORS - NATURAL OCCURRENCE AND ANIMAL-MODELS, The American journal of pathology, 145(5), 1994, pp. 994-1000
Authors:
KAYES LM
BURKE W
RICCARDI VM
BENNETT R
EHRLICH P
RUBENSTEIN A
STEPHENS K
Citation: Lm. Kayes et al., DELETIONS SPANNING THE NEUROFIBROMATOSIS-I GENE - IDENTIFICATION AND PHENOTYPE OF 5 PATIENTS, American journal of human genetics, 54(3), 1994, pp. 424-436
Citation: Vm. Riccardi, A CONTROLLED MULTIPHASE TRIAL OF KETOTIFEN TO MINIMIZE NEUROFIBROMA-ASSOCIATED PAIN AND ITCHING, Archives of dermatology, 129(5), 1993, pp. 577-581
Authors:
PULST SM
BASER ME
MAUTNER V
SAINZ J
NECHIPORUK A
KLEIN J
NELSON RA
RAGGE NK
RICCARDI VM
Citation: Sm. Pulst et al., PRESYMPTOMATIC DIAGNOSIS IN NF2 - USE OF NOVEL MICROSATELLITE MARKERS, NEUROIMAGING AND OCULAR EXAMINATIONS, American journal of human genetics, 53(3), 1993, pp. 488-488
Citation: Vm. Riccardi, TREATMENT STRATEGIES FOR NF-1 - PLEXIFORM NEUROFIBROMAS AS THE MOST IMPORTANT CONTRIBUTORS TO NF-1 MORTALITY AND CHRONIC MORBIDITY, American journal of human genetics, 53(3), 1993, pp. 495-495
Authors:
STEPHENS K
KAYES LM
BURKE W
RICCARDI VM
BENNETT R
EHRLICH P
RUBENSTEIN AE
Citation: K. Stephens et al., IDENTIFICATION AND PHENOTYPE OF 5 NEUROFIBROMATOSIS TYPE-1 PATIENTS WITH LARGE DELETIONS SPANNING THE NF1 GENE, American journal of human genetics, 53(3), 1993, pp. 1234-1234
Citation: Sl. Riccardi et Vm. Riccardi, HEALTH-CARE REFORM CONSEQUENCES FOR MEDICAL GENETIC SERVICES, American journal of human genetics, 53(3), 1993, pp. 1827-1827